(Q54041945)
Statements
A phase II and pharmacokinetic study of weekly 72-h topotecan infusion in patients with platinum-resistant and paclitaxel-resistant ovarian carcinoma (English)
Rose PG
Gordon NH
Fusco N
Fluellen L
Ingalls ST
scientific article